Change - Announcement Of Retirement Of Independent Director
Announcement Title | Change - Announcement of Cessation |
Date & Time of Broadcast | Jul 31, 2019 17:26 |
Status | New |
Announcement Sub Title | Retirement of Independent Director |
Announcement Reference | SG190731OTHRAMEJ |
Submitted By (Co./ Ind. Name) | Mary Judith de Souza |
Designation | Company Secretary |
Description (Please provide a detailed description of the event in the box below) | Retirement of Independent Director |
Additional Details | |
Name Of Person | Ng Eng Leng |
Age | 54 |
Is effective date of cessation known? | Yes |
If yes, please provide the date | 31/07/2019 |
Detailed Reason (s) for cessation | Retirement, as part of Ascendas Property Fund Trustee Pte. Ltd.'s regular Board succession and renewal process. |
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? | No |
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? | No |
Any other relevant information to be provided to shareholders of the listed issuer? | No |
Date of Appointment to current position | 01/04/2013 |
Does the AC have a minimum of 3 members (taking into account this cessation)? | Yes |
Number of Independent Directors currently resident in Singapore (taking into account this cessation) | 2 |
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months | 1 |
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) | Independent Director and Member of the Audit and Risk Committee |
Role and responsibilities | Non-executive |
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries | Nil |
Shareholding interest in the listed issuer and its subsidiaries? | No |
Past (for the last 5 years) | Nil |
Present | Hyphens Pharma International Limited |